In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine

Journal of Applied Toxicology

Volumn 28, Issue 2, 2008, Pages 156-163

  Bezerra, Daniel P ^a   De Castro, Fernanda O ^a   Alves, Ana Paula N N ^a   Pessoa, Cláudia ^a   De Moraes, Manoel Odorico ^a   Silveira, Edilberto R ^a   Lima, Mary Anne S ^a   Elmiro, Francisca Juliana M ^a   De Alencar, Nylane M N ^a   Mesquita, Rodney O ^a   Lima, Michael W ^a   Costa Lotufo, Letícia V ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

5 fluorouracil; Antitumor activity; Piperine; Piplartine; Toxicity

Indexed keywords

AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; FLUOROURACIL; PIPERINE; PIPLARTINE; UNCLASSIFIED DRUG; UREA;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

ALANINE TRANSAMINASE; ALKALOIDS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARTATE AMINOTRANSFERASES; BENZODIOXOLES; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; KIDNEY; LEUKOPENIA; LIVER; MICE; PIPERIDINES; PIPERIDONES; POLYUNSATURATED ALKAMIDES; SARCOMA 180; UREA;

ANIMALIA;

EID: 41149150829     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1261     Document Type: Article

References (26)

1. Annu K, Neelima T, Usha Z, Bedi KL. 1998. Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa. Mol. Cell Biochem. 189: 113-118.
2. Atal CK, Dhar KL, Singh J. 1975. The chemistry of Indian Piper species. Lloydia 38: 256-264.
3. Bezerra DP, Castro FO, Alves APNN, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM, Costa-Lotufo LV. 2006. In vivo growth-inhibition of sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper. Braz. J. Med. Biol. Res. 39: 801-807.
4. Bezerra DP, Militão GCG, Castro FO, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM, Costa-Lotufo LV. 2007. Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways. Toxicol. in Vitro 21: 1-8.
5. Bezerra DP, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM, Costa-Lotufo LV. 2005. Antiproliferative effects of two amides, piperine and piplartine, from Piper species. Z. Naturforsch. 60: 539-543.
6. Braz-Filho R, Souza MP, Mattos MEO. 1981. Piplartine-dimer A, a new alkaloid from Piper tuberculatum. Phytochemistry 20: 345-346.
7. Cragg MG, Newman J. 2005. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100: 72-79.
8. Dogra RKS, Khanna S, Shanker R. 2004. Immunotoxicological effects of piperine in mice. Toxicology 196: 229-236.
9. Duh CY, Wu YC. 1990. Cytotoxic pyridone alkaloids from the leaves of Piper aborescens. J. Nat. Prod. 53: 1575-1577.
10. Duh CY, Wu YC, Wang SK. 1990. Cytotoxic pyridone alkaloids from Piper aborescens. Phytochemistry 29: 2689-2691.
11. Katzung GB. 2003. Basic and Clinical Pharmacology, 9th edn. McGraw-Hill Medical: USA, 1088.
12. Kumar V, Abbas A, Fausto N, Robbins SL, Cotran RS. 2004. Pathology Basis of Disease, 7th edn. WB Saunders: China, 1552.
13. Lampe JW. 2003. Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am. J. Clin. Nutr. 78: 579S-583S.
14. McGee JOD, Isaacson PA, Wright NA. 1992. Oxford Textbook of Pathology: Pathology of Systems. Oxford University Press: New York; 1708.
15. Morinaga Y, Suga Y, Ehara S, Harada K, Nihei Y, Suzuki M. 2003. Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo. Cancer Sci. 94: 200-204.
16. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 16: 55-63.
17. Okawa Y, Murata Y, Kobayashi M, Suzuki ME, Suzuki S. 1992. Argumentation of host resistance to Candida albicans infection in ascite tumor-bearing mice. Microbiol. Immunol. 36: 517-521.
18. Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, Tyagi OM, Prasad AK, Wengel J, Olsen CE, Boll PM. 1997. Phytochemistry of the genus Piper. Phytochemistry 46: 597-673.
19. Pradeep CR, Kuttan G. 2002. Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin. Exp. Metastasis 19: 703-708.
20. Reen RK, Singh J. 1991. In vitro and in vivo inhibition of pulmonary cytochrome P450 activities by piperine. J. Exp. Biol. 29: 568-573.
21. Scheuer PJ, Lefkowitch JH. 2000. Drugs and toxins. In Liver Biopsy Interpretation, 6th edn, Scheuer PJ, Lefkowitch JH (eds). WB Saunders: London; 134-150.
22. Silva RV, Navickiene HMD, Kato MJ, Bolzani VS, Méda CI, Young MCM, Furlan M. 2002. Antifungal amides from Piper arboreum and Piper tuberculatum. Phytochemistry 59: 521-527.
23. Sunila ES, Kuttan G. 2004. Immunomodulatory and antitumor activity of Piper longum Linn, and piperine. J. Ethnopharmacol. 90: 339-346.
24. Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furuyama N, Nakajima N. 2001. Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother. Pharmacol. 47: 11-14.
25. Tsai IL, Lee FP, Wu CC, Duh CY, Ishikawa T, Chen JJ, Chen YC, Seki H, Chen IS. 2005. New cytotoxic cyclobutanoid amides, a new furanoid lignan and anti-platelet aggregation constituents from Piper arborescens. Planta Med. 71: 535-542.
26. Varley H, Gowenlock AM, Bell M. 1980. In Practical Clinical Biochemistry, Vol 1, 5th edn. William Heinmann Medical Books: London; 452.